Detected ·
ImmunoBiochem
——
ImmunoBiochem announced new funding from FACIT to advance its degrader–antibody conjugate (DAC) platform targeting treatment-resistant leukemia.
- Website
- www.immunobiochem.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-15 16:13:19 UTC
- Signal ID
- a246e985-06b7-4312-9b5b-181a47486973
As the API returns it
{
"id": "a246e985-06b7-4312-9b5b-181a47486973",
"created_at": "2026-09-15T16:13:19.564493Z",
"company_name": "ImmunoBiochem",
"company_website_url": "www.immunobiochem.com",
"company_linkedin_url": "https://www.linkedin.com/company/immunobiochem",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*ImmunoBiochem announced new funding from FACIT to advance its degrader–antibody conjugate (DAC) platform targeting treatment-resistant leukemia.*"
}